Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
PlexusDx's $298 genetic test analyzes fourteen peptide pathways including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313variants that influence how quickly your body responds to semaglutide and how strongly you'll experience appetite suppression
Published June 10, 2026
Tirzepatide is a groundbreaking medication primarily prescribed to treat type 2 diabetes
Tirzepatide has consistently shown greater weight loss than semaglutide at comparable doses in clinical trials, with some participants losing approximately 16% or more of their starting body weight. Choosing between the two compounds is a clinical decision based on individual health history, metabolic profile, and treatment goals, not simply which drug produces the largest number on paper
The answer depends on your training experience, but the principles remain consistent across levels
